Pharmaceutical Intermediates Market Size - Global Industry, Share, Analysis, Trends and Forecast 2023 - 2032
CHAPTER 1. Industry Overview of Pharmaceutical Intermediates Market
1.1. Definition and Scope
1.1.1. Definition of Pharmaceutical Intermediates
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Pharmaceutical Intermediates Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Pharmaceutical Intermediates Market By Type
1.2.3. Pharmaceutical Intermediates Market By Structure Building Blocks
1.2.4. Pharmaceutical Intermediates Market By End-User
1.2.5. Pharmaceutical Intermediates Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Pharmaceutical Companies of Suppliers
3.4.2. Bargaining Pharmaceutical Companies of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Pharmaceutical Intermediates Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Pharmaceutical Intermediates Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2022
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Pharmaceutical Intermediates Market By Type
4.1. Introduction
4.2. Pharmaceutical Intermediates Revenue By Type
4.2.1. Pharmaceutical Intermediates Revenue (USD Billion) and Forecast, By Type, 2020-2032
4.2.2. GMP
4.2.2.1. GMP Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
4.2.3. Non-GMP
4.2.3.1. Non-GMP Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 5. Pharmaceutical Intermediates Market By Structure Building Blocks
5.1. Introduction
5.2. Pharmaceutical Intermediates Revenue By Structure Building Blocks
5.2.1. Pharmaceutical Intermediates Revenue (USD Billion) and Forecast, By Structure Building Blocks, 2020-2032
5.2.2. Achiral Building Blocks
5.2.2.1. Achiral Building Blocks Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3. Chiral Building Blocks
5.2.3.1. Chiral Building Blocks Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 6. Pharmaceutical Intermediates Market By End-User
6.1. Introduction
6.2. Pharmaceutical Intermediates Revenue By End-User
6.2.1. Pharmaceutical Intermediates Revenue (USD Billion) and Forecast, By End-User, 2020-2032
6.2.2. Pharmaceutical Companies
6.2.2.1. Pharmaceutical Companies Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3. Contract Manufacturing Organizations (CMOs)
6.2.3.1. Contract Manufacturing Organizations (CMOs) Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.4. Research Organizations
6.2.4.1. Research Organizations Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 7. North America Pharmaceutical Intermediates Market By Country
7.1. North America Pharmaceutical Intermediates Market Overview
7.2. U.S.
7.2.1. U.S. Pharmaceutical Intermediates Revenue (USD Billion) and Forecast By Type, 2020-2032
7.2.2. U.S. Pharmaceutical Intermediates Revenue (USD Billion) and Forecast By Structure Building Blocks, 2020-2032
7.2.3. U.S. Pharmaceutical Intermediates Revenue (USD Billion) and Forecast By End-User, 2020-2032
7.3. Canada
7.3.1. Canada Pharmaceutical Intermediates Revenue (USD Billion) and Forecast By Type, 2020-2032
7.3.2. Canada Pharmaceutical Intermediates Revenue (USD Billion) and Forecast By Structure Building Blocks, 2020-2032
7.3.3. Canada Pharmaceutical Intermediates Revenue (USD Billion) and Forecast By End-User, 2020-2032
7.4. North America PEST Analysis
CHAPTER 8. Europe Pharmaceutical Intermediates Market By Country
8.1. Europe Pharmaceutical Intermediates Market Overview
8.2. U.K.
8.2.1. U.K. Pharmaceutical Intermediates Revenue (USD Billion) and Forecast By Type, 2020-2032
8.2.2. Canada Pharmaceutical Intermediates Revenue (USD Billion) and Forecast By Structure Building Blocks, 2020-2032
8.2.3. U.K. Pharmaceutical Intermediates Revenue (USD Billion) and Forecast By End-User, 2020-2032
8.3. Germany
8.3.1. Germany Pharmaceutical Intermediates Revenue (USD Billion) and Forecast By Type, 2020-2032
8.3.2. Germany Pharmaceutical Intermediates Revenue (USD Billion) and Forecast By Structure Building Blocks, 2020-2032
8.3.3. Germany Pharmaceutical Intermediates Revenue (USD Billion) and Forecast By End-User, 2020-2032
8.4. France
8.4.1. France Pharmaceutical Intermediates Revenue (USD Billion) and Forecast By Type, 2020-2032
8.4.2. France Pharmaceutical Intermediates Revenue (USD Billion) and Forecast By Structure Building Blocks, 2020-2032
8.4.3. France Pharmaceutical Intermediates Revenue (USD Billion) and Forecast By End-User, 2020-2032
8.5. Spain
8.5.1. Spain Pharmaceutical Intermediates Revenue (USD Billion) and Forecast By Type, 2020-2032
8.5.2. Spain Pharmaceutical Intermediates Revenue (USD Billion) and Forecast By Structure Building Blocks, 2020-2032
8.5.3. Spain Pharmaceutical Intermediates Revenue (USD Billion) and Forecast By End-User, 2020-2032
8.6. Rest of Europe
8.6.1. Rest of Europe Pharmaceutical Intermediates Revenue (USD Billion) and Forecast By Type, 2020-2032
8.6.2. Rest of Europe Pharmaceutical Intermediates Revenue (USD Billion) and Forecast By Structure Building Blocks, 2020-2032
8.6.3. Rest of Europe Pharmaceutical Intermediates Revenue (USD Billion) and Forecast By End-User, 2020-2032
8.7. Europe PEST Analysis
CHAPTER 9. Asia Pacific Pharmaceutical Intermediates Market By Country
9.1. Asia Pacific Pharmaceutical Intermediates Market Overview
9.2. China
9.2.1. China Pharmaceutical Intermediates Revenue (USD Billion) and Forecast By Type, 2020-2032
9.2.2. China Pharmaceutical Intermediates Revenue (USD Billion) and Forecast By Structure Building Blocks, 2020-2032
9.2.3. China Pharmaceutical Intermediates Revenue (USD Billion) and Forecast By End-User, 2020-2032
9.3. Japan
9.3.1. Japan Pharmaceutical Intermediates Revenue (USD Billion) and Forecast By Type, 2020-2032
9.3.2. Japan Pharmaceutical Intermediates Revenue (USD Billion) and Forecast By Structure Building Blocks, 2020-2032
9.3.3. Japan Pharmaceutical Intermediates Revenue (USD Billion) and Forecast By End-User, 2020-2032
9.4. India
9.4.1. India Pharmaceutical Intermediates Revenue (USD Billion) and Forecast By Type, 2020-2032
9.4.2. India Pharmaceutical Intermediates Revenue (USD Billion) and Forecast By Structure Building Blocks, 2020-2032
9.4.3. India Pharmaceutical Intermediates Revenue (USD Billion) and Forecast By End-User, 2020-2032
9.5. Australia
9.5.1. Australia Pharmaceutical Intermediates Revenue (USD Billion) and Forecast By Type, 2020-2032
9.5.2. Australia Pharmaceutical Intermediates Revenue (USD Billion) and Forecast By Structure Building Blocks, 2020-2032
9.5.3. Australia Pharmaceutical Intermediates Revenue (USD Billion) and Forecast By End-User, 2020-2032
9.6. South Korea
9.6.1. South Korea Pharmaceutical Intermediates Revenue (USD Billion) and Forecast By Type, 2020-2032
9.6.2. South Korea Pharmaceutical Intermediates Revenue (USD Billion) and Forecast By Structure Building Blocks, 2020-2032
9.6.3. South Korea Pharmaceutical Intermediates Revenue (USD Billion) and Forecast By End-User, 2020-2032
9.7. Rest of Asia-Pacific
9.7.1. Rest of Asia-Pacific Pharmaceutical Intermediates Revenue (USD Billion) and Forecast By Type, 2020-2032
9.7.2. Rest of Asia-Pacific Pharmaceutical Intermediates Revenue (USD Billion) and Forecast By Structure Building Blocks, 2020-2032
9.7.3. Rest of Asia-Pacific Pharmaceutical Intermediates Revenue (USD Billion) and Forecast By End-User, 2020-2032
9.8. Asia Pacific PEST Analysis
CHAPTER 10. Latin America Pharmaceutical Intermediates Market By Country
10.1. Latin America Pharmaceutical Intermediates Market Overview
10.2. Brazil
10.2.1. Brazil Pharmaceutical Intermediates Revenue (USD Billion) and Forecast By Type, 2020-2032
10.2.2. Brazil Pharmaceutical Intermediates Revenue (USD Billion) and Forecast By Structure Building Blocks, 2020-2032
10.2.3. Brazil Pharmaceutical Intermediates Revenue (USD Billion) and Forecast By End-User, 2020-2032
10.3. Mexico
10.3.1. Mexico Pharmaceutical Intermediates Revenue (USD Billion) and Forecast By Type, 2020-2032
10.3.2. Mexico Pharmaceutical Intermediates Revenue (USD Billion) and Forecast By Structure Building Blocks, 2020-2032
10.3.3. Mexico Pharmaceutical Intermediates Revenue (USD Billion) and Forecast By End-User, 2020-2032
10.4. Rest of Latin America
10.4.1. Rest of Latin America Pharmaceutical Intermediates Revenue (USD Billion) and Forecast By Type, 2020-2032
10.4.2. Rest of Latin America Pharmaceutical Intermediates Revenue (USD Billion) and Forecast By Structure Building Blocks, 2020-2032
10.4.3. Rest of Latin America Pharmaceutical Intermediates Revenue (USD Billion) and Forecast By End-User, 2020-2032
10.5. Latin America PEST Analysis
CHAPTER 11. Middle East & Africa Pharmaceutical Intermediates Market By Country
11.1. Middle East & Africa Pharmaceutical Intermediates Market Overview
11.2. GCC
11.2.1. GCC Pharmaceutical Intermediates Revenue (USD Billion) and Forecast By Type, 2020-2032
11.2.2. GCC Pharmaceutical Intermediates Revenue (USD Billion) and Forecast By Structure Building Blocks, 2020-2032
11.2.3. GCC Pharmaceutical Intermediates Revenue (USD Billion) and Forecast By End-User, 2020-2032
11.3. South Africa
11.3.1. South Africa Pharmaceutical Intermediates Revenue (USD Billion) and Forecast By Type, 2020-2032
11.3.2. South Africa Pharmaceutical Intermediates Revenue (USD Billion) and Forecast By Structure Building Blocks, 2020-2032
11.3.3. South Africa Pharmaceutical Intermediates Revenue (USD Billion) and Forecast By End-User, 2020-2032
11.4. Rest of Middle East & Africa
11.4.1. Rest of Middle East & Africa Pharmaceutical Intermediates Revenue (USD Billion) and Forecast By Type, 2020-2032
11.4.2. Rest of Middle East & Africa Pharmaceutical Intermediates Revenue (USD Billion) and Forecast By Structure Building Blocks, 2020-2032
11.4.3. Rest of Middle East & Africa Pharmaceutical Intermediates Revenue (USD Billion) and Forecast By End-User, 2020-2032
11.5. Middle East & Africa PEST Analysis
CHAPTER 12. Player Analysis Of Pharmaceutical Intermediates Market
12.1. Pharmaceutical Intermediates Market Company Share Analysis
12.2. Competition Matrix
12.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
12.2.2. New Product Launches and Product Enhancements
12.2.3. Mergers And Acquisition In Global Pharmaceutical Intermediates Market
12.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 13. Company Profile
13.1. Aceto Corporation
13.1.1. Company Snapshot
13.1.2. Business Overview
13.1.3. Financial Overview
13.1.3.1. Revenue (USD Billion), 2022
13.1.3.2. Aceto Corporation 2022 Pharmaceutical Intermediates Business Regional Distribution
13.1.4. Product /Service and Specification
13.1.5. Recent Developments & Business Strategy
13.2. A.R. Life Sciences Private Limited
13.3. BASF SE
13.4. Chemcon Speciality Chemicals Ltd.
13.5. Codexis, Inc.
13.6. Cycle Pharmaceuticals
13.7. Dextra Laboratories Ltd
13.8. Dishman Group
13.9. Easter Chemical Corporation, Pvt. Ltd.
13.10. Lianhe Chemical Technology Co., Ltd.
13.11. Midas Pharma GmbH
13.12. Sanofi Winthrop Industries
13.13. Vertellus Holdings LLC
13.14. ZCL Chemical Ltd.
Frequently Asked Questions
What was the market size of the global pharmaceutical intermediates in 2022?
The market size of pharmaceutical intermediates was USD 30.9 Billion in 2022.
What is the CAGR of the global pharmaceutical intermediates market from 2023 to 2032?
The CAGR of pharmaceutical intermediates is 6.2% during the analysis period of 2023 to 2032.
Which are the key players in the pharmaceutical intermediates market?
The key players operating in the global market are including Aceto Corporation, A.R. Life Sciences Private Limited, BASF SE, Chemcon Speciality Chemicals Ltd. Midas Pharma GmbH, Codexis, Inc., Cycle Pharmaceuticals, Dextra Laboratories Ltd, Dishman Group, Easter Chemical Corporation, Pvt. Ltd., Lianhe Chemical Technology Co., Ltd., Sanofi Winthrop Industries, Vertellus Holdings LLC, and ZCL Chemical Ltd.
Which region dominated the global pharmaceutical intermediates market share?
North America held the dominating position in pharmaceutical intermediates industry during the analysis period of 2023 to 2032.
Which region registered fastest CAGR from 2023 to 2032?
Asia-Pacific region exhibited fastest growing CAGR for market of pharmaceutical intermediates during the analysis period of 2023 to 2032.
What are the current trends and dynamics in the global pharmaceutical intermediates industry?
The current trends and dynamics in the pharmaceutical intermediates industry include increasing demand for generic drugs, growth in the pharmaceutical industry, and surging investment in research and development.
Which type held the maximum share in 2022?
The GMP type held the maximum share of the pharmaceutical intermediates industry.?
Select Licence Type
Connect with our sales team
Why Acumen Research And Consulting
100%
Customer Satisfaction
24x7
Availability - we are always there when you need us
200+
Fortune 50 Companies trust Acumen Research and Consulting
80%
of our reports are exclusive and first in the industry
100%
more data and analysis
1000+
reports published till date
